This cohort study evaluates the association between achieving a serum urate treatment target lower than 6 mg/dL and cardiovascular events among patients with gout who were newly prescribed urate-lowering treatment.
JAMA Internal Medicine published a clinical update in Research Highlights on 01 Mar 2026.
The item focuses on Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients With Gout.
Review the original article for the full source wording and details.